Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions

Journal of the American Society of Nephrology

Volumn 18, Issue 7, 2007, Pages 2094-2104

  Liu, Enqi ^a,b   Morimoto, Masatoshi ^a   Kitajima, Shuji ^a   Koike, Tomonari ^c   Yu, Ying ^c   Shiiki, Hideo ^d   Nagata, Michio ^e   Watanabe, Teruo ^a   Fan, Jianglin ^c  

^a SAGA UNIVERSITY   (Japan)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d Uda City Hospital   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ISOPROTEIN; VASCULOTROPIN; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; GLOMERULAR DYSFUNCTION; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HETEROZYGOSITY; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; MESANGIUM CELL; MICROANEURYSM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEINURIA; RABBIT; UPREGULATION;

EID: 34447265300     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006010075     Document Type: Article

References (41)

1. Ferrara N: Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25: 581-611, 2004
2. Simon M, Rockl W, Hornig C, Grone EF, Theis H, Weich HA, Fuchs E, Yayon A, Grone HJ: Receptors of vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [125I]VEGF binding sites. J Am Soc Nephrol 9: 1032-1044, 1998
3. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65: 2003-2017, 2004
4. Robert B, Zhao X, Abrahamson DR: Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol 279: F275-F282, 2000
5. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357, 1997
6. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
7. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239, 1999
8. Tsuchida K, Makita Z, Yamagishi S, Atsumi T, Miyoshi H, Obara S, Ishida M, Ishikawa S, Yasumura K, Koike T: Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42: 579-588, 1999
9. Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR: Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int 67: 167-177, 2005
10. Miyamoto K, Kitamoto Y, Tokunaga H, Takeya M, Ezaki T, Imamura T, Tomita K: Protective effect of vascular endothelial growth factor/ vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest 84: 1126-1136, 2004
11. Fan J, Watanabe T: Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther 99: 261-282, 2003
12. Kriz W, Hahnel B, Hosser H, Ostendorf T, Gaertner S, Kranzlin B, Gretz N, Shimizu F, Floege J: Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. J Am Soc Nephrol 14: 1904-1926, 2003
13. Ruther U, Tripodi M, Cortese R, Wagner EF: The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. Nucleic Acids Res 15: 7519-7529, 1987
14. Thomas S, Vanuystel J, Gruden G, Rodriguez V, Burt D, Gnudi L, Hartley B, Viberti G: Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 11: 1236-1243, 2000
15. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J: VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104: 913-923, 1999
16. Harper SJ, Xing CY, Whittle C, Parry R, Gillatt D, Peat D, Mathieson PW: Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond) 101: 439-446, 2001
17. Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 53: 2939-2949, 2004
18. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 284: F1263-F1273, 2003
19. Magil AB: Ideas in pathology. Focal and segmental glomerulosclerosis. Mod Pathol 4: 383-391, 1991
20. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60: 205-218, 1989
21. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148-160, 1992
22. Unemori EN, Ferrara N, Bauer EA, Amento EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153: 557-562, 1992
23. Mundel P, Kriz W: Structure and function of podocytes: An update. Anat Embryol (Berl) 192: 385-397, 1995
24. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993-1000, 2001
25. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094, 2002
26. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN: Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: Implications for diabetic glomerulopathy. Nephrol Dial Transplant 20: 1320-1328, 2005
27. Zachary I: Vascular endothelial growth factor: How it transmits its signal. Exp Nephrol 6: 480-487, 1998
28. Kim NH, Jung HH, Cha DR, Choi DS: Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 165: 617-624, 2000
29. Hoshi S, Nomoto K, Kuromitsu J, Tomari S, Nagata M: High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290: 177-184, 2002
30. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M: Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab Invest 82: 25-35, 2002
31. Garcia I, Miyazaki Y, Araki K, Araki M, Lucas R, Grau GE, Milon G, Belkaid Y, Montixi C, Lesslauer W, et al.: Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol 25: 2401-2407, 1995
32. Kitajima S, Liu E, Morimoto M, Koike T, Yu Y, Watanabe T, Imagawa S, Fan J: Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: A new model for Kasabach-Merritt syndrome. Lab Invest 85: 1517-1527, 2005
33. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, Fan J: C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance. Am J Pathol 167: 1139-1148, 2005
34. Helwig JJ, Zachary D, Bollack C: Isolation of glomeruli and tubular fragments from rabbit kidney. Urol Res 2: 55-59, 1974
35. Nolin TD, Colaizzi IV, Palevsky PM, Matzke GR, Frye RF: Rapid microtiter plate assay for determination of inulin in human plasma and dialysate. J Pharm Biomed Anal 28: 209-215, 2002
36. Brown SA: Evaluation of a single-injection method for estimating glomerular filtration rate in dogs with reduced renal function. Am J Vet Res 55: 1470-1473, 1994
37. Liu E, Kitajima S, Higaki Y, Morimoto M, Sun H, Watanabe T, Yamada N, Fan J: High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits. Metabolism 54: 132-138, 2005
38. Kanemoto K, Takahashi S, Shu Y, Usui J, Tomari S, Yan K, Hamazaki Y, Nagata M: Variable expression of podocyte-related markers in the glomeruloid bodies in Wilms tumor. Pathol Int 53: 596-601, 2003
39. Inada A, Nagai K, Arai H, Miyazaki J, Nomura K, Kanamori H, Toyokuni S, Yamada Y, Bonner-Weir S, Weir GC, Fukatsu A, Seino Y: Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am J Pathol 167: 327-336, 2005
40. Numaguchi Y, Okumura K, Harada M, Naruse K, Yamada M, Osanai H, Matsui H, Ito M, Murohara T: Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries. Cardiovasc Res 61: 177-185, 2004
41. Liang J, Liu E, Koike T, Yu Y, Kitajima S, Yingji J, Morimoto M, Watanabe T, Sasaguri Y, Watanabe S, Fan J: Macrophage elastase (MMP-12) accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 113: 1993-2001, 2006